Safe Labelling of Excipients in Medicines

Published: 20/7/2020

Deadline is approaching.

Guidance for medicine developers and companies on COVID-19

Published: 29/6/2020

EMA encourages medicine developers and pharmaceutical companies who are working on medications and vaccines in regard to COVID-19

Stakeholders: Regulatory expectations during COVID-19 pandemic

Published: 29/6/2020

How COVID-19 is affecting my GMP/GDP licence when renewal is approaching

EMA recommended granting conditional MA to Remdesivir

Published: 29/6/2020

Seems that first approved COVID treatment will go through registration

Brexit in pharma

Published: 4/10/2018

EMA and MHRA published Brexit Preparedness Business Continuity Plan, ready to address all challenges for your business

EUPV essential and challenges

Published: 4/10/2018

Fom pharmacovigilance contracts to daily routine PV activities with obligation reports .

Ready for pharmacovigilance inspection

Published: 4/10/2018

USFDA recent campaign of focus PV inspection in Asia, main challenges in social media.


Published: 4/10/2018

Driving business value from pharmaceutical serialisation, challenges you will be facing – strategic advice as well as pragmatic solution

Certified Centre of Excellence

Published: 10/8/2018

VergoResearch & Pharmazet at CPHI join venture

NEW entry to OTC

Published: 10/8/2018

Pharmazet Group is pleased to registration of first set of own products in OTC range as per our plans to enter to OTC market within CEE region.